Legal Opinion
Abraxis Bioscience, Inc. v. NAVINTA LLC
Court of Appeals for the Federal Circuit
Decided November 9, 2010No. 2009-1539PublishedCited by 91 opinions
1Opinion of the Court
Opinion for the court filed by Circuit Judge GAJARSA. Dissenting opinion filed by Circuit Judge NEWMAN.
GAJARSA, Circuit Judge.
Appellant Navinta LLC appeals from a final judgment of the United States District Court for the District of New Jersey finding, inter alia, that Navinta’s Abbreviated New Drug Application (“ANDA”) product would directly infringe claims 1-3 of U.S. Patent No. 4,870,086 (the “'086 patent”) and contribute to and induce infringement of claim 6 of the '086 patent. In addition, the district court found that Navinta’s ANDA product would contribute to and induce infringement…
2Cases cited21 opinions
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Keene Corp. v. United StatesSupreme Court of the United States · 1993
- Eli Lilly & Co. v. Medtronic, Inc.Supreme Court of the United States · 1990
- SanDisk Corp. v. STMicroelectronics, Inc.Court of Appeals for the Federal Circuit · 2007
- Arachnid, Inc., Plaintiff/cross-Appellant v. Merit Industries, Inc.Court of Appeals for the Federal Circuit · 1991
16 more not listed; retrieve them via the Exa API.
3Cited by91 opinions
- Intellectual Ventures I LLC v. Erie Indemnity CompanyCourt of Appeals for the Federal Circuit · 2017
- MSP Recovery Claims, Series LLC v. QBE Holdings, Inc.Court of Appeals for the Eleventh Circuit · 2020
- Alps South, LLC v. Ohio Willow Wood Co.Court of Appeals for the Federal Circuit · 2015
- Bard Peripheral Vascular, Inc. v. W.L. Gore & Associates, Inc.Court of Appeals for the Federal Circuit · 2015
- James v. J2 Cloud Services, LLCCourt of Appeals for the Federal Circuit · 2018
86 more not listed; retrieve them via the Exa API.